Polaris Quantum Biotech, Inc. — Form D/A
Polaris Quantum Biotech, Inc. of Durham, NC, a company, filed a Form D amendment with the SEC on 2020-05-05. The offering totals $600K, of which $485K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-05-05
- Form: D/A
- Accession: 0001804907-20-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $600K
- Amount sold: $485K
- Remaining: $115K
- Investors: 6
- Date of first sale: 2020-02-20
- Revenue range: Decline to Disclose
- SEC file number: 021-362029
Issuer
- Name: Polaris Quantum Biotech, Inc.
- CIK: 0001804907
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 201 W Main Street, Durham, NC, 27701
- Phone: 919-200-0592
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Doron Gordon | Director | Cary, NC |
| William Shipman | Director | Cary, NC |
| William Shipman | Executive Officer | Cary, NC |
| William J Shipman | Director | Durham, NC |
| William J Shipman | Executive Officer | Durham, NC |
| Doron J Gordon | Director | Durham, NC |
| Shahar Keinan | Director | Durham, NC |
| Shahar Keinan | Executive Officer | Durham, NC |
Other filings by this issuer (3)
More